BRS for STEMI and NSTE-ACS

Session comprising selected EuroPCR 2017 abstract submissions

Chairperson: R.J. Van Geuns

Presentations available when logged in:

  • Impact of BRS-specific implantation technique on device expansion in ACS. A pooled analysis from BVS STEMI First and BVS EXPAND studies
  • BRS STEMI first study: two-year clinical follow-up
  • A prospective evaluation of a standardised strategy for the use of a polymeric everolimus-eluting BRS in STEMI: the BVS STEMI strategy-it study
  • Acute and mid-term outcome following implantation of an everolimus-eluting BRS in patients with AMI: results from the GABI-R registry
  • Multicentric registry of BRS in spontaneous coronary artery dissection: a comparison with metallic stents